Knowledge Centre

How a cleverly packaged annuity plan sold as a keyman insurance product unravels under India's Income Tax Act — and why a straightforward Mutual Fund investment delivers the same returns with none of the legal exposure.

A case study based on actual policy illustrations.

In the corridors of corporate India, a quiet sales pitch has been making the rounds. Dress up an annuity product in the garb of a keyman insurance policy, let the company claim the ₹5 crore annual premium as a business expense, quietly assign the policy to the employee after three years, and then let the insurer advance loans against it — loans that are repaid from the policy's own annuity income. Clean, tax-efficient, guaranteed returns. Or so the story goes.

On paper, the proposition for a 55-year-old employee presents itself compellingly: invest ₹5 crore over 3 years, receive a post-tax XIRR of approximately 9.9%, and walk away at age 64 with a net gain of ₹2.15 crore. But beneath this polished illustration lies a structure riddled with legal infirmities — every one of which the Indian Income Tax Act is well-equipped to challenge.

"A plan that cannot survive scrutiny is not tax planning.
                It is tax risk dressed in a suit."

The Three-Act Structure 
— And Where It Breaks Down

The scheme operates in three distinct phases. In the first three years, the employer pays a premium of ₹5 crore per year and claims a deduction of ₹1.425 crore annually (28.5% tax rate) under Section 37(1) as a business expense.

In the fourth year, the policy is silently assigned to the employee — for no consideration. 

From year four onward, the insurer (PNB, MAX, or Aditya Birla) advances loans to the employee, which are notionally offset against the policy's annuity income.

 At year ten, when the employee is 64, the residual surrender value is distributed as income.

Each of these three acts carries its own legal landmine.

Act 1: The Keyman Deduction Claim

The Income Tax Act permits a deduction for keyman insurance premiums under Section 37(1) only when the policy is a genuine insurance contract — one that covers the risk of death or disability of a key employee and compensates the employer for the consequent business loss. The product in question carries no death benefit whatsoever. It is, by its own admission in the policy document, "purely designed as a financial structuring tool."

Legal Exposure — Section 37(1)

A policy with no death benefit cannot qualify as keyman insurance under the Income Tax Act. The Assessing Officer would treat the premium as a capital investment, not a revenue expense. All three years of deductions — totalling ₹4.275 crore — would be disallowed, with interest and penalty.

Act II — The "Free" Assignment

In year three, the employer assigns the policy to the employee without consideration. The structure presents this as a clean, tax-neutral step. It is not. Under Section 17(2) of the Income Tax Act, any benefit provided by an employer to an employee — including the transfer of a capital asset — is treated as a perquisite and taxed as salary in the hands of the employee. The surrender value at the time of assignment is ₹11.68 crore. This entire amount would constitute taxable salary income for the employee, attracting the highest marginal rate of 30%, plus surcharge and cess — a tax liability potentially exceeding ₹4 crore on a single transaction.

Act III — The Loan That Isn't Really a Loan

Post-assignment, the insurer advances loans to the employee. These loans are, by design, offset against the policy's own annuity income — meaning the employee never truly repays them from external resources. The Income Tax Act, under Section 2(24)(xi), specifically brings within the ambit of "income" any loan advanced by a trust or fund in which the employer has an interest, if the loan is structured to avoid tax. When a loan is designed to be extinguished by the income of the very asset used as collateral — with no real repayment obligation — tax authorities will look through the form to the substance. The loan becomes taxable income.

Why We Recommend Investing in Mutual Funds Instead

The mutual fund alternative assumes the same net-of-tax capital deployment (₹3.575 crore per year for three years, mirroring the post-tax investment under the insurance plan), invested at a conservative 11% CAGR — well within the long-term average of diversified equity funds.

The returns are "similar." But the comparison above is made assuming the insurance scheme survives all legal challenges intact — an assumption that, as we have established, does not hold. The mutual fund column, by contrast, is built on nothing more exotic than long-term equity growth and a straightforward LTCG tax calculation at 12.5% on gains above ₹1.25 lakh.

The reason the insurance scheme's returns appear comparable is precisely because — despite all the elaborate structuring — the underlying investment arithmetic is not fundamentally different from a plain vanilla equity investment. The "tax efficiency" it claims is built on deductions and exemptions that are either legally contestable or already incorporated into standard mutual fund taxation. Strip away the legal risk, and the mutual fund is the superior instrument on every dimension: liquidity, transparency, regulatory clarity, and judicial precedent.

A Word on GAAR

Since April 2017, India's General Anti-Avoidance Rule has empowered the Income Tax Department to look beyond the legal form of a transaction to its commercial substance. Under GAAR, an arrangement can be declared an "impermissible avoidance arrangement" if its main purpose — or one of its main purposes — is to obtain a tax benefit. The keyman annuity structure, with its explicit marketing of tax deductions and tax-free loan receipts as its central value proposition, is precisely the kind of arrangement GAAR was designed to address. In such cases, the tax consequences may be determined entirely at the discretion of the Assessing Officer, without the protection of any specific statutory provision.

Conclusion:

If the returns are the same, and the risk is vastly higher, the rational investor has only one choice.